TC
JNJ icon

Trilogy Capital’s Johnson & Johnson JNJ Stock Holding History

Trilogy Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
5,109
+4
+0.1% +$932 0.05% 185
2026
Q1 		$1.25M Sell
5,105
-241
-5% -$56.1K 0.06% 175
2025
Q4 		$1.11M Sell
5,346
-359
-6% -$71K 0.05% 182
2025
Q3 		$1.06M Buy
5,705
+81
+1% +$13.9K 0.05% 179
2025
Q2 		$859K Buy
5,624
+372
+7% +$57.2K 0.04% 189
2025
Q1 		$871K Buy
5,252
+263
+5% +$41.2K 0.05% 181
2024
Q4 		$722K Sell
4,989
-155
-3% -$24K 0.04% 194
2024
Q3 		$834K Buy
5,144
+195
+4% +$31.1K 0.04% 186
2024
Q2 		$723K Buy
4,949
+557
+13% +$82.8K 0.04% 191
2024
Q1 		$695K Buy
4,392
+2,099
+92% +$334K 0.04% 170
2023
Q4 		$359K Sell
2,293
-29
-1% -$4.45K 0.02% 194
2023
Q3 		$362K Sell
2,322
-625
-21% -$103K 0.02% 185
2023
Q2 		$501K Buy
2,947
+644
+28% +$104K 0.03% 174
2023
Q1 		$357K Sell
2,303
-157
-6% -$25.4K 0.03% 181
2022
Q4 		$435K Buy
2,460
+703
+40% +$121K 0.03% 166
2022
Q3 		$287K Buy
1,757
+251
+17% +$42.5K 0.03% 153
2022
Q2 		$267K Sell
1,506
-84
-5% -$15K 0.02% 138
2022
Q1 		$282K Sell
1,590
-60
-4% -$10.2K 0.02% 151
2021
Q4 		$282K Buy
1,650
+129
+8% +$21.1K 0.02% 148
2021
Q3 		$246K Sell
1,521
-8
-0.5% -$1.36K 0.02% 141
2021
Q2 		$259K Buy
1,529
+273
+22% +$45.2K 0.02% 139
2021
Q1 		$206K Buy
+1,256
New +$203K 0.02% 155
2018
Q4 		– Sell
-539
Closed -$74K – 363
2018
Q3 		$74K Buy
539
+11
+2% +$1.46K 0.01% 177
2018
Q2 		$64K Buy
528
+5
+1% +$624 0.01% 173
2018
Q1 		$67K Buy
+523
New +$70.7K 0.01% 156

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Trilogy Capital's JNJ Position: Q2 2026 in Review

Trilogy Capital increased its Johnson & Johnson (JNJ) stake by 0.08% in Q2 2026, buying an estimated $932 and bringing the position to 5,109 shares worth $1.3M. The position accounts for 0.05% of the portfolio, ranked #185.

Trilogy Capital first reported a position in JNJ in Q1 2018 and has held it in 25 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Trilogy Capital held 5,109 shares of Johnson & Johnson worth $1.3M as of Q2 2026.
  • Trilogy Capital bought 4 Johnson & Johnson shares in Q2 2026, an estimated $932.
  • Johnson & Johnson made up 0.05% of Trilogy Capital's portfolio in Q2 2026, its #185 holding.
  • Trilogy Capital first reported a position in Johnson & Johnson in Q1 2018 and has held it in 25 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.